|
1
|
Qian C and Cao X: Dendritic cells in the
regulation of immunity and inflammation. Semin Immunol. 35:3–11.
2018. View Article : Google Scholar
|
|
2
|
Banchereau J and Steinman RM: Dendritic
cells and the control of immunity. Nature. 392:245–252. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dong R, Cwynarski K, Entwistle A,
Marelli-Berg F, Dazzi F, Simpson E, Goldman JM, Melo JV, Lechler
RI, Bellantuono I, et al: Dendritic cells from CML patients have
altered actin organization, reduced antigen processing, and
impaired migration. Blood. 101:3560–3567. 2003. View Article : Google Scholar
|
|
4
|
Worbs T, Hammerschmidt SI and Förster R:
Dendritic cell migration in health and disease. Nat Rev Immunol.
17:30–48. 2017. View Article : Google Scholar
|
|
5
|
Kara PP, Ayhan A, Caner B, Gultekin M,
Ugur O, Bozkurt MF, Usubutun A and Uner A: Analysis of dendritic
cells in sentinel lymph nodes of patients with endometrial and
patients with cervical cancers. Int J Gynecol Cancer. 19:1239–1243.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Saalbach A, Janik T, Busch M, Herbert D,
Anderegg U and Simon JC: Fibroblasts support migration of
monocyte-derived dendritic cells by secretion of PGE2
and MMP-1. Exp Dermatol. 24:598–604. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Harizi H: Reciprocal crosstalk between
dendritic cells and natural killer cells under the effects of
PGE2 in immunity and immunopathology. Cell Mol Immunol.
10:213–221. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yen JH, Khayrullina T and Ganea D:
PGE2-induced metallo-proteinase-9 is essential for
dendritic cell migration. Blood. 111:260–270. 2008. View Article : Google Scholar
|
|
9
|
Scandella E, Men Y, Legler DF, Gillessen
S, Prikler L, Ludewig B and Groettrup M: CCL19/CCL21-triggered
signal transduction and migration of dendritic cells requires
prostaglandin E2. Blood. 103:1595–1601. 2004. View Article : Google Scholar
|
|
10
|
Rubio MT, Means TK, Chakraverty R, Shaffer
J, Fudaba Y, Chittenden M, Luster AD and Sykes M: Maturation of
human monocyte-derived dendritic cells (MoDCs) in the presence of
prostaglandin E2 optimizes CD4 and CD8 T cell-mediated responses to
protein antigens: Role of PGE2 in chemokine and cytokine
expression by MoDCs. Int Immunol. 17:1561–1572. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Huang J, Diao G, Zhang Q, Chen Y, Han J
and Guo J: E6-regulated overproduction of prostaglandin E2 may
inhibit migration of dendritic cells in human papillomavirus
16-positive cervical lesions. Int J Oncol. 56:921–931.
2020.PubMed/NCBI
|
|
12
|
Baratelli FE, Heuzé-Vourc'h N, Krysan K,
Dohadwala M, Riedl K, Sharma S and Dubinett SM: Prostaglandin
E2-dependent enhancement of tissue inhibitors of
metalloproteinases-1 production limits dendritic cell migration
through extracellular matrix. J Immunol. 173:5458–5466. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lutz MB, Kukutsch N, Ogilvie AL, Rössner
S, Koch F, Romani N and Schuler G: An advanced culture method for
generating large quantities of highly pure dendritic cells from
mouse bone marrow. J Immunol Methods. 223:77–92. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Han P, Hanlon D, Sobolev O, Chaudhury R
and Edelson RL: Ex vivo dendritic cell generation-A critical
comparison of current approaches. Int Rev Cell Mol Biol.
349:251–307. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Burns S, Thrasher AJ, Blundell MP,
Machesky L and Jones GE: Configuration of human dendritic cell
cytoskeleton by Rho GTPases, the WAS protein, and differentiation.
Blood. 98:1142–1149. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hu ZQ, Xue H, Long JH, Wang Y, Jia Y, Qiu
W, Zhou J, Wen ZY, Yao WJ and Zeng Z: Biophysical properties and
motility of human mature dendritic cells deteriorated by vascular
endothelial growth factor through cytoskeleton remodeling. Int J
Mol Sci. 17:17562016. View Article : Google Scholar :
|
|
17
|
López-Colomé AM, Lee-Rivera I,
Benavides-Hidalgo R and López E: Paxillin: A crossroad in
pathological cell migration. J Hematol Oncol. 10:502017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Nakanishi M and Rosenberg DW: Multifaceted
roles of PGE2 in inflammation and cancer. Semin
Immunopathol. 35:123–137. 2013. View Article : Google Scholar
|
|
19
|
Hooper KM, Yen JH, Kong W, Rahbari KM, Kuo
PC, Gamero AM and Ganea D: Prostaglandin E2 inhibition of IL-27
production in murine dendritic cells: A novel mechanism that
involves IRF1. J Immunol. 198:1521–1530. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gill SK, Yao Y, Kay LJ, Bewley MA,
Marriott HM and Peachell PT: The anti-inflammatory effects of
PGE2 on human lung macrophages are mediated by the
EP4 receptor. Br J Pharmacol. 173:3099–3109. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Esaki Y, Li Y, Sakata D, Yao C,
Segi-Nishida E, Matsuoka T, Fukuda K and Narumiya S: Dual roles of
PGE2-EP4 signaling in mouse experimental
autoimmune encephalomyelitis. Proc Natl Acad Sci USA.
107:12233–12238. 2010. View Article : Google Scholar
|
|
22
|
Poloso NJ, Urquhart P, Nicolaou A, Wang J
and Woodward DF: PGE2 differentially regulates
monocyte-derived dendritic cell cytokine responses depending on
receptor usage (EP2/EP4). Mol Immunol.
54:284–295. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Osma-Garcia IC, Punzón C, Fresno M and
Díaz-Muñoz MD: Dose-dependent effects of prostaglandin E2 in
macrophage adhesion and migration. Eur J Immunol. 46:677–688. 2016.
View Article : Google Scholar
|
|
24
|
Clambey ET, McNamee EN, Westrich JA,
Glover LE, Campbell EL, Jedlicka P, de Zoeten EF, Cambier JC,
Stenmark KR, Colgan SP and Eltzschig HK: Hypoxia-inducible factor-1
alpha-dependent induction of FoxP3 drives regulatory T-cell
abundance and function during inflammatory hypoxia of the mucosa.
Proc Natl Acad Sci USA. 109:E2784–E2793. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Flück K, Breves G, Fandrey J and Winning
S: Hypoxia-inducible factor 1 in dendritic cells is crucial for the
activation of protective regulatory T cells in murine colitis.
Mucosal Immunol. 9:379–390. 2016. View Article : Google Scholar
|
|
26
|
Dang EV, Barbi J, Yang HY, Jinasena D, Yu
H, Zheng Y, Bordman Z, Fu J, Kim Y, Yen HR, et al: Control of
T(H)17/T(reg) balance by hypoxia-inducible factor 1. Cell.
146:772–784. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lee JH, Elly C, Park Y and Liu YC: E3
ubiquitin ligase VHL regulates hypoxia-inducible factor-1α to
maintain regulatory T cell stability and suppressive capacity.
Immunity. 42:1062–1074. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shibata M, Ham K and Hoque MO: A time for
YAP1: Tumorigenesis, immunosuppression and targeted therapy. Int J
Cancer. 143:2133–2144. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang G, Lu X, Dey P, Deng P, Wu CC, Jiang
S, Fang Z, Zhao K, Konaparthi R, Hua S, et al: Targeting
YAP-dependent MDSC infiltration impairs tumor progression. Cancer
Discov. 6:80–95. 2016. View Article : Google Scholar :
|
|
30
|
Hodgson MC, Deryugina EI, Suarez E, Lopez
SM, Lin D, Xue H, Gorlov IP, Wang Y and Agoulnik IU: INPP4B
suppresses prostate cancer cell invasion. Cell Commun Signal.
12:612014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lin H, Rothe K, Chen M, Wu A, Babaian A,
Yen R, Zeng J, Ruschmann J, Petriv OI, O'Neill K, et al: The
miR-185/PAK6 axis predicts therapy response and regulates survival
of drug-resistant leukemic stem cells in CML. Blood. 136:596–609.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
De Laere M, Berneman ZN and Cools N: To
the brain and back: Migratory paths of dendritic cells in multiple
sclerosis. J Neuropathol Exp Neurol. 77:178–192. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Seyfizadeh N, Muthuswamy R, Mitchell DA,
Nierkens S and Seyfizadeh N: Migration of dendritic cells to the
lymph nodes and its enhancement to drive anti-tumor responses. Crit
Rev Oncol Hematol. 107:100–110. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Weinlich R, Bortoluci KR, Chehab CF,
Serezani CH, Ulbrich AG, Peters-Golden M, Russo M and
Amarante-Mendes GP: TLR4/MYD88-dependent, LPS-induced synthesis of
PGE2 by macrophages or dendritic cells prevents
anti-CD3-mediated CD95L upregulation in T
cells. Cell Death Differ. 15:1901–1909. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yokoyama U, Iwatsubo K, Umemura M, Fujita
T and Ishikawa Y: The prostanoid EP4 receptor and its signaling
pathway. Pharmacol Rev. 65:1010–1052. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Regan JW: EP2 and EP4 prostanoid receptor
signaling. Life Sci. 74:143–153. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
van Helden SF, Oud MM, Joosten B, Peterse
N, Figdor CG and van Leeuwen FN: PGE2-mediated podosome
loss in dendritic cells is dependent on actomyosin contraction
downstream of the RhoA-Rho-kinase axis. J Cell Sci. 121:1096–1106.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Schurch NJ, Schofield P, Gierliński M,
Cole C, Sherstnev A, Singh V, Wrobel N, Gharbi K, Simpson GG,
Owen-Hughes T, et al: How many biological replicates are needed in
an RNA-seq experiment and which differential expression tool should
you use? RNA. 22:839–851. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Xi WD, Liu YJ, Sun XB, Shan J, Yi L and
Zhang TT: Bioinformatics analysis of RNA-seq data revealed critical
genes in colon adenocarcinoma. Eur Rev Med Pharmacol Sci.
21:3012–3020. 2017.PubMed/NCBI
|
|
40
|
Witteck A, Yao Y, Fechir M, Förstermann U
and Kleinert H: Rho protein-mediated changes in the structure of
the actin cytoskeleton regulate human inducible NO synthase gene
expression. Exp Cell Res. 287:106–115. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Meyer-Wentrup F and Burdach S: Efficacy of
dendritic cell generation for clinical use: Recovery and purity of
monocytes and mature dendritic cells after immunomagnetic sorting
or adherence selection of CD14+ starting populations. J
Hematother Stem Cell Res. 12:289–299. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Marques GS, Silva Z and Videira PA:
Antitumor efficacy of human monocyte-derived dendritic cells:
Comparing effects of two monocyte isolation methods. Biol Proced
Online. 20:42018. View Article : Google Scholar : PubMed/NCBI
|
